Page 15 - Continuous Manufacturing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Continuous Manufacturing of Liposomal Products DIANT Phar Image Credit: InProcess Continuous manufacturing is starting to gain increased interest over traditional batch processing for nanoparticle drug delivery systems. DIANT Pharma Inc. (DIANT) provides a turnkey solution for the continuous processing of nanoparticles by offering multiple modules and integrated process analytical technology as a single closed-system. Inventors of the Continuous Manufacturing System DIANT is a startup co-founded by Antonio Costa, Ph.D. and Diane Burgess, Ph.D.  In 2020, DIANT licensed their ...

Continuus lands $69.3m US drug manufacturing contract The small-molecule pharmaceuticals manufacturer secured a DoD/HHS government contract to manufacture critical medicines for a range of conditions. Continuus Pharmaceuticals, a firm that uses proprietary integrated continuous manufacturing (ICM) technology to manufacture drugs, has been granted a $69.3m (57 EUR) contract to manufacture three different medicines. The contract, awarded by the US Department of Defense (DoD) and Department of Health and Human Services (HHS), also will be used for construction of the ...

Innovations in OSD Decrease Font This DFE series of educational webinars looks at innovations in Oral Solid Dose Forms with the emergence of advanced technologies such as Continuous Manufacturing and 3D printing. The benefits and regulatory challenges will be explored, including how to manage the risk from the impact of excipient variability. In 3D the conflict between the novel materials which may be required, and regulatory acceptability, is a challenge. Perceived regulatory uncertainty may limit the widespread adoption of Continuous Manufacturing, despite the benefi...

ISPE Invited to Participate in DAF ACT Initiative to Support Domestic Manufacturing of Active Pharmaceutical Ingredients Share Article ISPE announced their participation in the Department of the Air Force Acquisition COVID-19 Task Force (DAF ACT) to advise Regulatory, Technical, and Workforce elements favorable to creating a more robust and sustainable domestic pharmaceutical manufacturing base for Active Pharmaceutical Ingredients (APIs). This partnership aligns with ISPE’s mission to support the international pharmaceutical industry and multiple programs we actively lead, including the Dr...